Abstract:Objective To investigate the mortality trends and life loss due to pancreatic cancer death among residents in Suzhou City from 2006 to 2020, so as to provide insights into the management of pancreatic cancer. Methods The data pertaining to the death of pancreatic cancer in Suzhou City from 2006 to 2020 were collected from the Jiangsu provincial mortality surveillance system. The crude mortality, standardized mortality, years of potential life lost ( YPL L), rate of YPLL ( YPLLR ), average years of life lost ( AYLL ) and annual percent change (APC) were calculated to analyze the changing trend in mortality and life loss due to pancreatic cancer. Results The crude mortality of pancreatic cancer was 13.57/105 in Suzhou City from 2006 to 2020, appearing a tendency towards a rise ( P<0.05) with APC of 2.95%. The standardized mortality of pancreatic cancer was 6.39/105. The crude mortality of pancreatic cancer was 15.14/105 in men and 12.06/105 in women, which both showed a tendency towards a rise ( P<0.05 ) with APC of 3.18% and 2.73%. The crude mortality of pancreatic cancer appeared a tendency towards a decline in residents at ages of 30 to 45 years and 45 to 60 years ( P<0.05 ), with APC of -4.93% and -1.63%, and appeared a tendency towards a rise in residents at ages of 60 years and greater ( P<0.05 ), with APC of 0.53%. The YPLL and YPLLR of pancreatic cancer were 55 340 person-years and 0.06% in Suzhou City from 2006 to 2020, while the AYLL of pancreatic cancer was 9.81 years per person, which appeared a tendency towards a decline ( P<0.05 ), with APC of -2.35%. Conclusions The crude mortality of pancreatic cancer appeared a tendency towards a rise in Suzhou City from 2006 to 2020, and the AYLL showed a tendency towards a decline. Health education and screening of pancreatic cancer should be reinforced among men and the elderly.
王临池, 黄春妍, 华钰洁, 吴学飞, 陆艳. 2006—2020年苏州市胰腺癌死亡及减寿分析[J]. 预防医学, 2022, 34(2): 185-189.
WANG Linchi, HUANG Chunyan, HUA Yujie, WU Xuefei, LU Yan. Analysis of mortality and life loss due to pancreatic cancer in SuzhouCity from 2006 to 2020. Preventive Medicine, 2022, 34(2): 185-189.
[1] SUNG H,FERLAY J,SIEGEL R L.Global cancer statistics2020:GLOBOCAN stimates of incidence and mortality worldwide for 36 cancers in 185 countries[J/OL].CA Cancer J Clin,2021[2021-11-10].https: //acsjournals.onlinelibrary.wiley.com/doi/pdf direct/10.3322/caac.21660. [2] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30. [3] 郝捷,魏文强.2019中国肿瘤登记年报[D].北京:人民卫生出版社,2021:156-160. HAO J,WEI W Q.China cancer registry annual repert,2019[D].Beijing:People's Medical Publishing House,2021:156-160. [4] 蔡洁,陈宏达,卢明,等.2005—2015年中国胰腺癌发病与死亡趋势分析[J].中华流行病学杂志,2021,42(5):794-800. CAI J,CHEN H D,LU M,et al.Trend analysis on morbidity and mortality of pancreatic cancer in China,2005-2015[J].Chin J Epidemiol,2021,42(5):794-800. [5] 王临池,陆艳,胡一河.2004—2013年苏州市居民恶性肿瘤死亡及减寿分析[J].现代预防医学,2015,42(7):1302-1305. WANG L C,LU Y,HU Y H,et al.Death causes and life lost of malignant tumor among residents in Suzhou City,2004- 2013[J].Mod Prev Med,2015,42(7):1302-1305. [6] 俞浩,武鸣,林萍,等.江苏省新增死因监测点2011—2012年死亡漏报调查[J].江苏预防医学,2014,25(4):29-32. YU H,WU M,LIN P,et al.Investigation of under-reporting of death in newly added disease surveillance points in Jiangsu from 2011 to 2012[J].Jiangsu J Prev Med,2014,25(4):29-32. [7] 周晓燕,龚巍巍,潘劲,等.浙江省公共卫生监测区居民死亡漏报情况分析[J].预防医学,2021,33(10):994-997. ZHOU X Y,GONG W W,PAN J,et al.Under reporting deaths in public health surveillance areas of Zhejiang Province[J].Prev Med,2021,33(10):994-997. [8] 韩仁强,武鸣,缪伟刚,等.2016年江苏省恶性肿瘤流行情况分析[J].实用肿瘤学杂志,2020,34(4):291-297. HAN R Q,WU M,MIAO W G,et al.Malignant tumor epidemiology in Jiangsu province,2016[J].Pract Oncol J,2020,34(4):291-297. [9] 王亮亮,丁高恒,陈莉莉,等.2009—2015年甘肃省肿瘤登记地区胰腺癌流行特征及变化趋势分析[J].实用肿瘤学杂志,2021,35(3):200-206. WANG L L,DING G H,CHEN L L,et al.Trends of incidence and mortality of pancreatic cancer in Gansu cancer registration areas,2009-2015[J].Pract Oncol J,2021,35(3):200-206. [10] 孙惠昕,张茂祥,贾海晗,等.2013—2017年黑龙江省居民胰腺癌发病和死亡趋势[J].预防医学,2021,33(6):599-601. SUN H X,ZHANG M X,JIA H H,et al.Incidence and mortality of pancreatic cancer in Heilongjiang Province from 2013 to 2017[J].Prev Med,2021,33(6):599-601. [11] 梁智恒,李柱明,魏矿荣.1970—2015年广东省中山市胰腺癌发病与死亡分析[J].中国肿瘤,2020,29(10):751-757. LIANG Z H,LI Z M,WEI K R.Incidence and mortality of pancreatic cancer in Zhongshan City of Guangdong Province,1970-2015[J].China Cancer,2020,29(10):751-757. [12] 纪威,张良,应焱燕,等.2010—2018年宁波市胰腺癌发病和死亡趋势分析[J].预防医学,2020,3(8):805-808. JI W,ZHANG L,YING Y Y,et al.Trend of pancreatic cancer incidence and mortality in Ningbo from 2010 to 2018[J].Prev Med,2020,3(8):805-808. [13] LUCAS A L,MALVEZZI M,CARIOLI G,et al.Global trends in pancreatic cancer mortality from 1980 through 2013 and predictions for 2017[J].Clin Gastroenterol Hepatol,2016,14(10):1452-1462. [14] KLEINA P.Pancreatic cancer epidemiology:understanding the role of lifestyle and inherited risk factors[J].Nat Rev Gastroenterol Hepatol,2021,18(7):493-502. [15] 刘成成,石春雷,石菊芳,等.2015—2017年中国城市居民肿瘤预防意识健康素养及相关因素分析[J].中华预防医学杂志,2020,54(1):47-53. LIU C C,SHI C L,SHI J F,et al.Study on the health literacy and related factors of the cancer prevention consciousness among urban residents in China from 2015 to 2017.[J].Chin J Prev Med,2020,54(1):47-53.